MULTICENTRE DOUBLE-BLIND STUDY OF EFFECT OF INTRATHECALLY ADMINISTERED NATURAL HUMAN FIBROBLAST INTERFERON ON EXACERBATIONS OF MULTIPLE SCLEROSIS☆

[1]  V. Tăriceanu.  [The interferon system]. , 1987, Viata medicala; revista de informare profesionala si stiintifica a cadrelor medii sanitare.

[2]  C. Landel,et al.  MAPPING THE ACTION OF INTERFERON ON PRIMATE BRAIN , 1987 .

[3]  T. Munsat,et al.  Intrathecal administration of natural human nterferon alpha in amyotrophic lateral sclerosis , 1986, Neurology.

[4]  R. Lisak.  Interferon and multiple sclerosis , 1986, Annals of neurology.

[5]  D. Silberberg,et al.  Coronavirus infection induces H-2 antigen expression on oligodendrocytes and astrocytes. , 1986, Science.

[6]  L. Jacobs,et al.  Intrathecal interferon in the treatment of multiple sclerosis. Patient follow-up. , 1985, Archives of neurology.

[7]  R. Welsh,et al.  Interferon enhances the susceptibility of virus-infected fibroblasts to cytotoxic T cells , 1985, The Journal of experimental medicine.

[8]  M. Hallett,et al.  Confusional syndrome in thalamic stroke , 1984, Neurology.

[9]  Mora-Flores Js,et al.  Indomethacin reduces the side effects of intrathecal interferon. , 1984 .

[10]  R. Smith,et al.  Clinical Use of Interferons: Central Nervous System Disorders , 1984 .

[11]  T. Munsat,et al.  Indomethacin reduces the side effects of intrathecal interferon. , 1984, The New England journal of medicine.

[12]  G. Wong,et al.  Inducible expression of H–2 and Ia antigens on brain cells , 1984, Nature.

[13]  L. Jacobs,et al.  Intrathecal interferon as treatment of multiple sclerosis. A planned multicenter study. , 1983, Archives of neurology.

[14]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[15]  S. Levine,et al.  Inhibition of passive localized experimental allergic encephalomyelitis by interferon. , 1983, International archives of allergy and applied immunology.

[16]  C. Berry.  Intrathecal interferon for multiple sclerosis. , 1982, Science.

[17]  T. Aune,et al.  Activation of a suppressor T-cell pathway by interferon. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Onsrud.  Enhancement of suppressor cell generation in human mixed lymphocyte cultures by interferon. , 1982, International archives of allergy and applied immunology.

[19]  S. L. Abreu,et al.  Suppression of experimental allergic encephalomyelitis by interferon. , 1982, Immunological communications.

[20]  J. Mussini,et al.  [Immunology of multiple sclerosis]. , 1982, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris.

[21]  L. Jacobs,et al.  Intrathecal interferon reduces exacerbations of multiple sclerosis. , 1981, Science.

[22]  H. Prange,et al.  Intrathecal use of interferon in encephalitis. , 1981, The New England journal of medicine.

[23]  J. Misset,et al.  Intrathecal interferon in meningeal leukemia. , 1981, The New England journal of medicine.

[24]  S. Cook,et al.  Multiple sclerosis and viruses , 1980, Neurology.

[25]  B. Bloom,et al.  Interferon as a mediator of human lymphocyte suppression , 1980, The Journal of experimental medicine.

[26]  M. Oldstone,et al.  T suppressor (TG) lymphocytes fluctuate in parallel with changes in the clinical course of patients with multiple sclerosis. , 1979, Journal of Immunology.

[27]  R. Loewenson,et al.  The design of clinical studies to assess therapeutic efficacy in multiple sclerosis , 1979, Neurology.

[28]  J. Antel,et al.  Suppressor cell function in multiple sclerosis: Correlation with clinical disease activity , 1979, Annals of neurology.

[29]  J. Dunnick,et al.  Clinical trials with exogenous interferon: summary of a meeting. , 1979, The Journal of infectious diseases.

[30]  E. Weinmann,et al.  Administration of human interferon to rabies virus-infected monkeys after exposure. , 1977, The Journal of infectious diseases.

[31]  E. De Clercq,et al.  Intrathecal administration of interferon in neonatal herpes. , 1975, The Journal of pediatrics.

[32]  R. Hernández,et al.  Circulating interferon in man after administration of exogenous human leukocyte interferon. , 1975, Journal of the National Cancer Institute.

[33]  E D Acheson,et al.  Multiple sclerosis,: A reappraisal , 1972 .

[34]  N. Geschwind,et al.  Cooperative study in the evaluation of therapy in multiple sclerosis , 1970, Neurology.

[35]  J. Kurtzke,et al.  Further notes on disability evaluation in multiple sclerosis, with scale modifications , 1965, Neurology.